<DOC>
	<DOCNO>NCT01057693</DOCNO>
	<brief_summary>Patients switch current medication painful diabetic peripheral neuropathy evaluate safety efficacy pregabalin compare placebo . All patient receive pregabalin , half patient receive placebo point study .</brief_summary>
	<brief_title>Study Of Pregabalin ( Lyrica ) In Patients With Painful Diabetic Peripheral Neuropathy</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Pain</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Patients must painful diabetic peripheral neuropathy receive treatment condition . Patients pain condition participate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Diabetic peripheral neuropathy</keyword>
	<keyword>Lyrica</keyword>
	<keyword>pregabalin</keyword>
	<keyword>pain</keyword>
</DOC>